Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Third Rock Ventures adds biologics expert Kamen

November 10, 2010 5:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Robert Kamen, a former executive-in-residence at Oxford BioScience Partners, has joined life sciences-focused venture capital firm Third Rock Ventures LLC in the same role, helping to find and develop new companies.

Federal Register: Medical Devices; General and Plastic Surgery Devices; Classification of Tissue Adhesive With Adjunct Wound Closure Device Intended for Topical Approximation ...

November 10, 2010 5:31 am | by U.S. Food & Drug Administration | News | Comments

The FDA is classifying the tissue adhesive with adjunct wound closure device intended for topical approximation into class II (special controls).

TOPICS:

Federal Register: Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Tissue Adhesive With Adjunct Wound Closure Device ...

November 10, 2010 5:30 am | by U.S. Food & Drug Administration | News | Comments

This guidance document describes a means by which tissue adhesives with adjunct wound closure devices intended for the topical approximation of skin may comply with the requirement of special controls for class II devices.

TOPICS:
Advertisement

Luminex Corporation to Present at Stephens Fall Investment Conference

November 10, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Nov. 10, 2010 /- Luminex Corporation (Nasdaq: LMNX ) today announced that management will present at the Stephens Fall Investment Conference to be held November 16-17, 2010, in New York. (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) (Logo:  ...

TOPICS:

Hologic Encourages Health Professionals to Get the Facts About Women's Imaging at RSNA 2010

November 10, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Nov. 10, 2010 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will focus on products...

TOPICS:

Cynosure to Present at 4th Annual Maxim Group Growth Conference

November 10, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

WESTFORD, Mass., Nov. 10, 2010 /- Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the Maxim Group Growth Conference in New York on Thursday, November 18. The...

TOPICS:

Dehaier Medical to Participate in MEDICA International Trade Fair

November 10, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

BEIJING, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will...

TOPICS:

New Trauma Market Research Data Covering Multiple Geographies Released by Millennium Research Group

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

TORONTO, Nov. 10, 2010 /- Millennium Research Group (MRG), the global authority on medical technology market intelligence, has released its latest trauma research data for multiple geographies, including the US, Canada, Europe, Japan, Brazil, India, and China. MRG's trauma reports cover...

TOPICS:
Advertisement

American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 10, 2010 /- The American Council on Exercise (ACE), America's leading authority on fitness and the largest nonprofit fitness certification, education and training organization in the world, today announced the launch of a national campaign that will focus on eliminating...

TOPICS:

Quotient Clinical and Bend Research Announce Collaboration to Accelerate Advancement of New Medicines

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

BEND, Ore. and NOTTINGHAM, England, Nov. 10, 2010 /- Bend Research Inc. ( www.bendres.com ), a leading independent drug-formulation development and manufacturing company, and Quotient Clinical, a business unit of Quotient Bioresearch ("Quotient," www.quotientbioresearch.com ), a leading...

TOPICS:

PHC Announces 19.2% Increase in Fiscal 2011 First Quarter Revenues

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

PEABODY, Mass., Nov. 10, 2010 /- PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC ), a leading provider of inpatient and outpatient behavioral health services, today reported financial results for the Company's 2011 first fiscal quarter ended September 30, 2010. First Fiscal...

TOPICS:

Lotus Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2010 Financial Results

November 10, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

BEIJING, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS ) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it...

TOPICS:

Sales Underpinned by 100% Enterprise and OEM Customer Renewal Rate, Addition of New Large Enterprise Customers

November 10, 2010 3:45 am | by The Associated Press | News | Comments

ActiveState, the dynamic language experts offering solutions for Perl (http://www.activestate.com/perl) , Python (http://www.activestate.com/python) , and Tcl (http://www.activestate.com/tcl) , announced today a robust sales revenue growth rate of 43% for the third quarter of 2010 and an ...

LED Industry & LED Manufacturing Technologies for a Market Briefing

November 10, 2010 1:38 am | by I-Micronews | News | Comments

?The packaged LED market is experiencing tremendous growth with an expected CAGR of 28.2% between 2009 and 2015?.

Global PET SPECT Market (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) to be US$ 10.3 Billion by 2015

November 10, 2010 1:36 am | by Bio-Medicine.Org | News | Comments

Global PET SPECT Market (Positron Emission Tomography) & SPECT (Single Photon Emission Computed... -- DALLAS, November 10, 2010 /PRNewswi...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading